Elshad Hasanov MD, PhD, Debra Nana Yeboa MD, Mathew D. Tucker MD, Todd A. Swanson MD, PhD, Thomas Hendrix Beckham MD, PhD, Brian Rini MD, Chibawanye I. Ene MD, PhD, Merve Hasanov MD, Sophie Derks MD, Marion Smits MD, PhD, Shaan Dudani MD, MPH, Daniel Y. C. Heng MD, MPH, Priscilla K. Brastianos MD, Axel Bex MD, PhD, Sahin Hanalioglu MD, PhD, Jeffrey S. Weinberg MD, Laure Hirsch MD, Maria I. Carlo MD, Ayal Aizer MD, MHS, Paul David Brown MD, Mehmet Asim Bilen MD, Eric Lin Chang MD, Jerry Jaboin MD, PhD, James Brugarolas MD, PhD, Toni K. Choueiri MD, Michael B. Atkins MD, Bradley A. McGregor MD, Lia M. Halasz MD, Toral R. Patel MD, Scott G. Soltys MD, David F. McDermott MD, James Bradley Elder MD, Mustafa K. Baskaya MD, James B. Yu MD, Robert Timmerman MD, Michelle Miran Kim MD, Melike Mut MD, James Markert MD, Kathryn Beal MD, Nizar M. Tannir MD, George Samandouras MD, Frederick F. Lang MD, Rachel Giles MD, Eric Jonasch MD
{"title":"An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma","authors":"Elshad Hasanov MD, PhD, Debra Nana Yeboa MD, Mathew D. Tucker MD, Todd A. Swanson MD, PhD, Thomas Hendrix Beckham MD, PhD, Brian Rini MD, Chibawanye I. Ene MD, PhD, Merve Hasanov MD, Sophie Derks MD, Marion Smits MD, PhD, Shaan Dudani MD, MPH, Daniel Y. C. Heng MD, MPH, Priscilla K. Brastianos MD, Axel Bex MD, PhD, Sahin Hanalioglu MD, PhD, Jeffrey S. Weinberg MD, Laure Hirsch MD, Maria I. Carlo MD, Ayal Aizer MD, MHS, Paul David Brown MD, Mehmet Asim Bilen MD, Eric Lin Chang MD, Jerry Jaboin MD, PhD, James Brugarolas MD, PhD, Toni K. Choueiri MD, Michael B. Atkins MD, Bradley A. McGregor MD, Lia M. Halasz MD, Toral R. Patel MD, Scott G. Soltys MD, David F. McDermott MD, James Bradley Elder MD, Mustafa K. Baskaya MD, James B. Yu MD, Robert Timmerman MD, Michelle Miran Kim MD, Melike Mut MD, James Markert MD, Kathryn Beal MD, Nizar M. Tannir MD, George Samandouras MD, Frederick F. Lang MD, Rachel Giles MD, Eric Jonasch MD","doi":"10.3322/caac.21729","DOIUrl":null,"url":null,"abstract":"<p>Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited understanding of brain metastasis tumor and immune biology, drivers of resistance to systemic treatment, and their overall poor prognosis. Current data support a multimodal treatment strategy with radiation treatment and/or surgery. Nonetheless, the optimal approach for the management of brain metastases from renal cell carcinoma remains unclear. To improve patient care, the authors sought to standardize practical management strategies. They performed an unstructured literature review and elaborated on the current management strategies through an international group of experts from different disciplines assembled via the network of the International Kidney Cancer Coalition. Experts from different disciplines were administered a survey to answer questions related to current challenges and unmet patient needs. On the basis of the integrated approach of literature review and survey study results, the authors built algorithms for the management of single and multiple brain metastases in patients with renal cell carcinoma. The literature review, consensus statements, and algorithms presented in this report can serve as a framework guiding treatment decisions for patients. <b>CA Cancer J Clin. 2022;72:454-489.</b></p>","PeriodicalId":137,"journal":{"name":"CA: A Cancer Journal for Clinicians","volume":null,"pages":null},"PeriodicalIF":503.1000,"publicationDate":"2022-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.3322/caac.21729","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CA: A Cancer Journal for Clinicians","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.3322/caac.21729","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 11
Abstract
Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited understanding of brain metastasis tumor and immune biology, drivers of resistance to systemic treatment, and their overall poor prognosis. Current data support a multimodal treatment strategy with radiation treatment and/or surgery. Nonetheless, the optimal approach for the management of brain metastases from renal cell carcinoma remains unclear. To improve patient care, the authors sought to standardize practical management strategies. They performed an unstructured literature review and elaborated on the current management strategies through an international group of experts from different disciplines assembled via the network of the International Kidney Cancer Coalition. Experts from different disciplines were administered a survey to answer questions related to current challenges and unmet patient needs. On the basis of the integrated approach of literature review and survey study results, the authors built algorithms for the management of single and multiple brain metastases in patients with renal cell carcinoma. The literature review, consensus statements, and algorithms presented in this report can serve as a framework guiding treatment decisions for patients. CA Cancer J Clin. 2022;72:454-489.
期刊介绍:
CA: A Cancer Journal for Clinicians" has been published by the American Cancer Society since 1950, making it one of the oldest peer-reviewed journals in oncology. It maintains the highest impact factor among all ISI-ranked journals. The journal effectively reaches a broad and diverse audience of health professionals, offering a unique platform to disseminate information on cancer prevention, early detection, various treatment modalities, palliative care, advocacy matters, quality-of-life topics, and more. As the premier journal of the American Cancer Society, it publishes mission-driven content that significantly influences patient care.